Dr. Giles has been President, CEO and Director of Vapogenix since July 2017. She joined Vapogenix in 2009 as Chief Scientific Officer and has provided scientific and drug development leadership, in addition to making significant contributions to overall company strategy and to successful fundraising. Dr. Giles has held international leadership positions in large and small pharmaceutical companies and has wide experience in drug discovery and development from target validation, through clinical studies to final regulatory submission. She recently led Vapogenix through the successful completion of a Phase II clinical trial in Australia.
Jay joined Biogen in 2011 as an MBA Intern in the Supply Chain Group. Jay has 10 years of supply chain experience and 8 years of that has been in the Clinical Supply Industry. Prior to joining Biogen, Jay worked for a third party logistics provider that serviced clients like KFC and McDonalds where he gained his core supply chain skills as a management trainee. Through his stint at Biogen, Jay has worked in Clinical Logistics and Clinical Planning managing end to end Clinical Supply Chain Activities for a number of trials in all phases and has also been involved in a number of pre-approval regulatory inspections. Jay has also led multiple process improvement initiatives at Biogen to streamline overall clinical supply end to end processes and system integrations.
With over 15 years’ experience in clinical research, following 15 years in academia, Dr. Jacob ‘s experience working within the corporate infrastructure as well as establishing successful sponsor/site relationships, has allowed her to successfully develop and launch both large and small clinical trials across the research spectrum – retrospective, post market and IDE studies. She has been a study coordinator, then a CRA, a manager, director and is now Vice President of Research and Clinical Affairs at several medical device companies.
Jane Hart has worked in the Clinical Research Industry for over 22 years, with 5 of those years in the Medical Device Industry. She joined KCI in 2017 leading the Clinical Operations, Data Management, Biostatistics and Global Safety departments. Her team is focused on generating evidence to support the safe and effective use of KCI products primarily through company sponsored and investigator sponsored research. Jane started her career in Australia working in breast cancer research and relocated to the US 17 years ago. She is experienced with executing pre and post market studies globally for both drug and devices. Highlights of studies she has managed include FDA approval of a nanocoated cardiac stent, hormonal therapy for breast cancer and chemotherapy for hematological malignancies.
Jane is currently a member of the Association of Clinical Research Professionals (ACRP) and is PMP certified with the Project Management Institute. In addition, Jane is a graduate of Charles Sturt University, Australia.
Patrick T. Moran is the founding board member of the Texas Cannabis Industry Association. Beginning October of 2013, he started to apply his professional experience to the emerging cannabis industry. He maintains Texas State Bar licensure and invested time & energy into the last three Texas legislative sessions, to help advance cannabis law reform. Mr. Moran is also founder and CEO of Pebble Global Holdings (www.pebble.life) an emerging bio-pharmaceutical company committed to natural plant solutions that include CBD-based products. Coming from a family with three generations of medical professionals on his mother’s side and six generations of industrial-scale agriculture & entrepreneurship on his father’s, he has led the company’s R&D, guided overall strategy and successful fundraising. Post Texas Hemp legalization, he is now helping advise TCIA coming into the 2020 elections and using the results of Pebble’s in-house clinical trial to inform subsequent larger scale studies.
After several years in the rescue service, Jakob Böttger specialized in the field of rescue engineering. As head of planning and deployment of the fire brigade, he is primarily active in risk assessment and in the derivation of measures in emergency plans for railway incidents. These include projects at the Lötschberg base tunnel, the Gotthard and Ceneri base tunnel and a number of smaller tunnels operated by BLS Netz AG.
Zoran Antonijevic is Head of Biometrics at MedSource. He held executive positions in Pharmaceutical Companies and CROs and has designed more than 100 clinical trials in numerous therapeutic areas, many of which included adaptive designs. Zoran is a long-time Chair and leader of the DIA Adaptive Design Scientific Working Group. He has authored numerous papers and scientific presentations and was editor of books “Optimization of Pharmaceutical R&D Programs and Portfolios” and “Platform Trials in Drug Development”.
Bin Pan brings over 25 years of clinical research experience with a strong focus on oncology clinical development. Throughout her career, she has advanced through roles in clinical operations, trial management, and oversight across pharma, biotech, and CRO companies. Bin’s scientific expertise is anchored by her PhD in Molecular Biology, equipping her with deep insights into innovative treatment strategies. Passionate about precision medicine and immuno-oncology, she is also committed to addressing the unmet needs of patients—especially those battling rare cancers.
Tom is currently serving as the Associate Director of Business Process and Integration in Takeda’s Clinical Supply Chain group within the Lexington, MA office. Within this role, he is responsible for the optimization and utilization of the in-house Clinical Supply Management Database (SmartSupplies) currently deployed for all of Takeda’s clinical trials managed out of the Lexington, MA office. In addition, Tom is also responsible for the Clinical Supply chain integration activities related to any mergers and / or acquisitions made by Takeda’s Lexington office. Prior to joining Shire, Tom lead the Logistics and Supply Chain Operations teams at two large Contract Manufacturing Organizations. Tom has been responsible for the implementation of multiple ERP systems / IRT solutions at a number of organizations throughout his career. These software solutions include SAP, Oracle, as well as a number of software applications developed “in-house”. Tom has over 15 combined years of Clinical Supply experience from both the CMO and Pharma sides of the industry.
